FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

E. Jean Carroll is a mess for the administration that won’t go away

Smithsonian Accused of Rewriting Nixon History with False Impeachment Claim

Fact Check: Ken Paxton Absolutely Didn’t Let a Sex Offender Go Free – Here’s What Really Happened

Scary stories to tell seniors

Lithuania warns Russian economy is ‘built on war’ and Baltic states are likely next target

Karen Bass appears to liken Spencer Pratt to Trump amid tightening LA mayoral race

Hasan Piker defends pro-communist, anti-ICE Singham network activists as ‘wonderful people’

California neighborhood on alert after bat found near sidewalk tests positive for rabies virus

Charter bus driver who allegedly caused crash killing 5 in Virginia charged with involuntary manslaughter

Trump floats replacing 250th anniversary concert with massive MAGA rally after artists pull out

Senate candidate Graham Platner sent explicit texts to multiple women while married, wife says: report

NYPD investigating after surveillance video captures group entering sewers through manholes

Manhunt underway for suspect after Virginia deputy killed, another injured in ambush; $10K reward offered

Delaney Hall protests intensify as far-left activists, ICE supporters converge in New Jersey

Gov. Sherrill blames ICE, defends rioters after deploying troopers to quell violent mob

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”